In a study of 67 neonates (half opioid-exposed), plasma brain-derived neurotrophic factor (BDNF) was significantly elevated in opioid-exposed neonates compared to non-exposed neonates, suggesting that plasma BDNF might correlate with NAS severity (Subedi et al., 2017). This evidence concerns the gene BDNF and neonatal abstinence syndrome.